Enhancement of c-erbA proto-oncogene expression by glucocorticoid hormones in S49.1 lymphoma cells

Biochim Biophys Acta. 1989 Nov 2;1009(2):188-90. doi: 10.1016/0167-4781(89)90100-0.

Abstract

The modifications of the mRNA levels of the c-myc and c-erbA proto-oncogenes during the dexamethasone-induced decrease of S49.1 cell proliferation have been studied. The levels of c-myc mRNA decreased significantly between 3 and 18 h after dexamethasone (1 microM) treatment. In contrast, a significant increase in the levels of a 2.6 kb c-erbA mRNA was observed between 6 and 18 h after hormone treatment. Cycloheximide treatment of S49.1 cells increased the levels of c-erbA RNA and overcome the enhancing effect of dexamethasone on the expression of this proto-oncogene, suggesting that ongoing protein synthesis is necessary to elicit this hormone effect. The associated decrease of cell proliferation and changes in c-myc and c-erbA mRNA levels after dexamethasone treatment suggest that such oncogenes might be involved in the dexamethasone-mediated control of lymphoid cell growth.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cycloheximide / pharmacology
  • Dexamethasone / pharmacology*
  • Gene Expression Regulation / drug effects*
  • Kinetics
  • Mice
  • Proto-Oncogene Proteins / genetics*
  • Proto-Oncogenes*
  • RNA, Messenger / genetics
  • Receptors, Thyroid Hormone / genetics
  • Tumor Cells, Cultured

Substances

  • Proto-Oncogene Proteins
  • RNA, Messenger
  • Receptors, Thyroid Hormone
  • Dexamethasone
  • Cycloheximide